In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]
- Ehab Atallah(corresponding author),
- Hagop Kantarjian,
- University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Letter
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Page 14 (1 page)Journal (Volume, Issue Number)
Nature Medicine (Volume 13, Issue 1)Publication milestones
- Published - 01/2007
Publication status
Published - 01/2007
ISSN
1078-8956Publication IDs
- Scopus: 33846086176
- PubMed: 17206119
- ORCID: /0000-0002-8636-1071/work/68811272
Publication metrics
Metrics
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
2.94
SciVal
Author count
3
SciVal
citations
32
SciVal
Paper percentile
81
PlumX, opens in new tab
Citation count
39
Captures
10
